THE PROGNOSTIC-SIGNIFICANCE OF PROLIFERATING CELL NUCLEAR ANTIGEN IN BREAST-CANCER - CORRELATION WITH DNA PLOIDY, C-ERBB-2 EXPRESSION, HISTOPATHOLOGY, LYMPH-NODE METASTASES AND PATIENT SURVIVAL
M. Noguchi et al., THE PROGNOSTIC-SIGNIFICANCE OF PROLIFERATING CELL NUCLEAR ANTIGEN IN BREAST-CANCER - CORRELATION WITH DNA PLOIDY, C-ERBB-2 EXPRESSION, HISTOPATHOLOGY, LYMPH-NODE METASTASES AND PATIENT SURVIVAL, International journal of oncology, 2(6), 1993, pp. 985-989
We have investigated the relationship of PCNA expression with establis
hed clinicopathologic and biologic prognostic variables and determined
its prognostic value in 91 patients with operable invasive breast can
cer. The PCNA index varied within a range of 0-74% with the average in
all specimens equal to 17%. When the tumors were separated on the bas
is of the mean value of the PCNA index, PCNA expression did not correl
ate with clinical stage, histologic type or grade, tumor size, axillar
y or internal mammary lymph node metastases, DNA ploidy, or c-erbB-2 e
xpression. Moreover, PCNA expression did not appear to be a significan
t prognostic factor by univariate or multivariate analyses. Therefore,
we conclude that PCNA expression does not correlate with established
clinicopathologic and biologic prognostic factors and may not be usefu
l in clinical practice to identify a poor prognostic group of patients
with breast cancer.